Home / Private raises / Kura Oncology, Inc.

Kura Oncology, Inc.

Biotechnology · San Diego, California · $5.0M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-18D (new)$5.0M$25.0M1506(b)EquityNov 9SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryBiotechnology
LocatedSan Diego, California
EntityCorporation
IncorporatedDelaware
SEC CIK1422143

People named in the latest filing

NameRole
Troy WilsonExecutive Officer, Director
Kathleen FordExecutive Officer
Jennifer FulkExecutive Officer
Francis BurrowsExecutive Officer
Mollie LeoniExecutive Officer
Teresa BairExecutive Officer
Brian PowlExecutive Officer
Faheem HasnainDirector
Helen CollinsDirector
Thomas MalleyDirector
Diane ParksDirector
Carol SchaferDirector
Mary SzelaDirector
Michael VasconcellesDirector

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?